Impairment of the Cognitive Flow in the Development of a Depressive Disorder and Suicidal Ideas
NCT ID: NCT03674580
Last Updated: 2018-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
67 participants
OBSERVATIONAL
2015-05-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Cognitive Inhibition Disorders in Depressed Older Suicide Attempters
NCT01333215
Characterization of Suicidal Depression
NCT05046587
Cognition, Sleep, Neurophysiology of Suicidal Depressed Patients
NCT04813835
Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients
NCT02737540
Predictors of Suicidal Behavior in Depression
NCT02904005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* In the first place, that suicidals presents a mental load (cognitive saturation) and an activity pain behaviour of their space of the thought by extremely painful peripheral cognitive movements (impression that the brain is saturated of thoughts, turbulences, internal movements)
* Secondly, that suicidals produces a surplus of representations of action, such takes out that their vision of the world is saturated of a not integrable kinaesthetic imaging by the subject.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suicidal patients
No intervention. Follow-up of the suicidal patients
Follow-up of the suicidal patients
No intervention. Follow-up of the suicidal patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow-up of the suicidal patients
No intervention. Follow-up of the suicidal patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Knowledge of the French language
* patient who have signed of the form of consent,
* patient presenting one anxio-depressive disorder(confusion) with or without suicidal episode.
Exclusion Criteria
* the not knowledge of the French language,
* patient who have refused the protocol.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital NOVO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
BAUDOIN Thierry, PH
Role: PRINCIPAL_INVESTIGATOR
Rene Dubos Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Rene Dubos
Pontoise, Val d'Oise, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRD1515
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.